Antiviral drug susceptibility assays: Going with the flow

Antiviral Research

Volumn 43, Issue 1, 1999, Pages 1-21

  McSharry, James J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Antiviral drugs; Drug susceptibility assays; Flow cytometry

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET; GANCICLOVIR; INDINAVIR; LAMIVUDINE; MONOCLONAL ANTIBODY; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; SAQUINAVIR; VIRUS ANTIGEN; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; DRUG SCREENING; DRUG SENSITIVITY; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; VIRUS DETECTION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELLS, CULTURED; CYTOMEGALOVIRUS; DRUG EVALUATION, PRECLINICAL; FLOW CYTOMETRY; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; SIMPLEXVIRUS;

EID: 0032799256     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00039-X     Document Type: Review

References (55)

1. Boeckh M., Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin. Microbiol. Rev. 11:1998;533-554.
2. Boden D., Markowitz M. Resistance to human immunodeficiency virus type 1 protease inhibitors. Antimicrob. Agents Chemother. 42:1998;2775-2783.
3. Cecilia D., Kewalramani V.K., O'Leary J. et al. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J. Virol. 72:1998;6988-6996.
4. Cockerill F.R. Genetic methods for assessing antimicrobial resistance. Antimicrob. Agents Chemother. 43:1999;199-212.
5. Crumpacker C. Ganciclovir. New Engl. J. Med. 335:1996;721-729.
6. Crumpacker C.S., Baldanti F, Boeck M et al. Drug resistance in cytomegalovirus: current knowledge and implications for patient management. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12(Suppl. 1):1996;S1-S22.
7. De Clercq E. In search of a selective antiviral chemotherapy. Clin. Microbiol. Rev. 10:1997;674-693.
8. De Clercq E. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection. Antivir. Res. 38:1998;153-179.
9. De Jong M.D., Boucher C.A.B., Danner S.A. et al. Summary of the international consensus symposium on management of HIV, CMV, and hepatitis virus infections. Antivir. Res. 37:1998;1-16.
10. De La Iglesia P., Melon S., Lopez B. et al. Rapid screening tests for determining in vitro susceptibility of herpes simplex virus clinical isolates. J. Clin. Microbiol. 36:1998;2389-2391.
11. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods. 89:1986;271-277.
12. Dorenbaum A., Venkateswaran K.S., Yang G., Comeau A.M., Wara D., Vyas G.N. Transmission of HIV-1 in infants born to seropositive mothers: PCR amplified proviral DNA detected by flow cytometric analysis of immunoreactive beads. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:1997;35-42.
13. Elmendorf S., McSharry J.J., Laffin J., Fogleman D., Lehman J.M. Detection of an early cytomegalovirus antigen with two color quantitative flow cytometry. Cytometry. 9:1988;254-260.
14. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin. Microbiol. Rev. 12:1999;286-297.
15. Erice A., Gil-Roda C., Perez J.-L. et al. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J. Infect. Dis. 175:1997;1087-1092.
16. Field A.K., Biron K.K. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin. Microbiol. Rev. 7:1994;1-13.
17. Fiscus S.A., DeGruttola V., Gupta P. et al. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial. J. Infect. Dis. 171:1995;305-311.
18. Gerna G., Sarasini A., Percivalle E., Zavattoni M., Baldanti F., Revello M.G. Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture positive blood samples. J. Clin. Microbiol. 33:1995;738-741.
19. Gervaix A., West D., Leoni L.M., Richman D.D., Wong-Staal F., Corbeil J. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl Acad. Sci. USA. 94:1997;4653-4658.
20. Gibellini D., Zauli G., Re M.C. et al. In situ polymerase chain reaction technique revealed by flow cytometry as a tool for gene detection. Anal. Biochem. 228:1995;252-258.
21. Goolsby C., Gray H., Docherty J.J., Todd P. Flow cytometric detection of herpes simplex virus type 2 infected and transformed cells by immunoexzymatic and by indirect immunofluorescence staining. Cytometry. 9:1988;126-130.
22. Imbert-Marcille B.M., Robillard N., Poirier A.S. et al. Development of a method for direct quantitation of cytomegalovirus antigenemia by flow cytometry. J. Clin. Microbiol. 35:1997;2665-2669.
23. Jabs D.A., Enger C., Forman M., Dunn J.P. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. Antimicrob. Agents Chemother. 42:1998;2240-2244.
24. Kesson A.M., Zeng F., Cunningham A.L., Rawlinson W.D. The use of flow cytometry to detect antiviral resistance in human cytomegalovirus. J. Virol. Methods. 71:1998;177-186.
25. Lathey J.L., Fiscus S.A., Rasheed S. et al. Optimization of quantitative culture assay for human immunodeficiency virus from plasma. J. Clin. Microbiol. 32:1994;3064-3067.
26. Lipson S.M., Soni M., Biondo F.X., Shepp D.H., Kaplan M.H., Sun T. Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistance. Diagn. Microbiol Infect. Dis. 28:1997;123-129.
27. Lurain N.S., Spafford L.E., Thompson K.D. Mutation in the UL97 open reading frame of human cytomegalovirus stranis resistant to ganciclovir. J. Virol. 68:1994;4427-4431.
28. Lurain N.S., Ammons H.C., Kapell K.S., Yeldandi V.V., Garrity E.R., Sun T. Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor. Transplantation. 62:1996;497-502.
29. Mazeron M.C., Jahn G., Plachter B. Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J. Gen. Virol. 73:1992;2699-2703.
30. McSharry J.J. Uses of flow cytometry in virology. Clin. Microbiol. Rev. 7:1994;576-604.
31. McSharry J.J., Costantino R., McSharry M.B., Venezia R.A., Lehman J.M. Rapid detection of herpes simplex virus in clinical samples by flow cytometry after amplification in tissue culture. J. Clin. Microbiol. 28:1990;1864-1866.
32. McSharry J.J., Lurain N.S., Drusano G.L. et al. Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates. J. Clin. Microbiol. 36:1998;958-964.
33. McSharry J.J., Lurain N.S., Drusano G.L. et al. Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates. Antimicrob. Agents Chemother. 42:1998;2326-2331.
34. McSharry, J.J., Luarain, N.S., McDonough, A.C. et al., 1998c. Drug susceptibilities of human cytomegalovirus (HCMV) clinical isolates as determined by flow cytometry. Abs. 38th ICAAC, San Diego, CA, 24-27 September 1998, Abstract No. H-106.
35. McSharry, J.J., Talarico, C., Davis, M., Biron, K.K., 1998d. Comparison of phenotypic assays for determining susceptibility of human cytomegalovirus (HCMV) to 1263W94 and ganciclovir. Abstr. 38th ICAAC, San Diego, CA, 24-27 September 1998, Abstract No. H-107.
36. McSharry, J.J., Lurain, N.S., Davis, M., Talarico, C.L., Biron, K.K., Crumpacker, C.S., 1999a. Comparison of the in vitro antiviral activities of 1263W94, ganciclovir, foscarnet, and cidofovir for human cytomegalovirus (HCMV) clinical isolates as determined by flow cytometry and plaque reduction assays. Abstr. 12th Int. Conf. on Antiviral Research, Jerusalem, Israel, 21-25 March 1999, Abstract No. 95.
37. McSharry, J.J., McDonough, A.C., Olson, B.A., Drusano, G.L., Lurain, N.S., Crumpacker, C.S., 1999b. Comparison of the in vitro antiviral activities of RPRCMV423, RPR127025, and ganciclovir for human cytomegalovirus (HCMV) clinical isolates as determined by flow cytometry. Abstr. 99th Gen. Meet. of the American Society for Microbiology, Chicago, IL, 30 May-3 June 1999, Abstract No. S18.
38. Palestine A.G., Polis M.A., DeSmet M.D. et al. A randomized controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 115:1991;665-673.
39. Patterson B.K., Till M., Otto P. et al. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cyotmetry. Science. 260:1993;976-979.
40. Patterson B.K., Goolsby C., Hodara V., Lohman K.L., Wolinsky S.M. Detection of CD4+ T cells harboring human immunodeficiency virus type 1 DNA by flow cytometry using simultaneous immunophenotyping and PCR-driven in situ hybridization: evidence of epitope masking of the CD4 cell surface molecule in vivo. J. Virol. 69:1995;4316-4322.
41. Patterson B.K., Mosiman V.L., Cantarero L., Furtado M., Bhattacharya M., Goolsby C. Detection of HIV-RNA-positive monocytes in peripheral blood of HIV-positive patients by simultaneous flow cytometric analysis of intracellular HIV RNA and cellular phentotype. Cytometry. 31:1998;265-274.
42. Pavic I., Hartmen A., Zimmermann A. et al. Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. Antimicrob. Agents Chemother. 41:1997;2686-2692.
43. Pepin J.-M., Simon F., Dussault A., Collins G., Dazza M.-C., Brun-Vezinet F. Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J. Clin. Microbiol. 30:1992;2917-2920.
44. Polis M.A., Spooner K.M., Baird B.F. et al. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob. Agents Chemother. 39:1995;882-886.
45. Re M.C., Furlini G., Gibellini D. et al. Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometry analysis of the product of an in situ PCR assay. J. Clin. Microbiol. 32:1994;2152-2157.
46. Robinson J.P., Darzynkiewicz Z., Dean P. et al. Current Protocols in Cytometry. 1999;Wiley, New York.
47. Rosenthal K.S., Hodnichak C.M., Summers J.L. Flow cytometric evaluation of anti-herpes drugs. Cytometry. 8:1987;392-395.
48. Safrin S., Elbeik T., Mills J. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates. J. Infect. Dis. 169:1994;879-882.
49. Shapiro H.M. Practical Flow Cytometry. 3rd edn:1995;Wiley-Liss, New York.
50. Sullivan V., Talarico C.L., Stanat S.C., Davis M., Coen D.M., Biron K.K. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 358:1992;162-164.
51. Stanat S.C., Reardon J.E., Erice E.J., Jordan M.C., Drew W.L., Biron K.K. Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob. Agents Chemother. 35:1991;1291-1297.
52. Tebas P., Scholl D., Jollick J., McHarg K., Arens M., Olivo P.D. A rapid assay to screen for drug resistant herpes samples virus. J. Infect. Dis. 177:1998;217-220.
53. Watson J.V. Introduction to Flow Cytometry. 1991;Cambridge University Press, New York.
54. Yang G., Garhwal S., Olson J.C., Vyas G.N. Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin-labeled probes. Clin. Diagn. Lab. Immunol. 1:1994;26-31.
55. Yang G., Olson J.C., Pu R., Vyas G.N. Flow cytometric detection of human immunodeficiency virus type 1 proviral DNA by the polymerase chain reaction incorporating digoxigenin-or fluorescein-labeled dUTP. Cytometry. 21:1995;197-202.